Skip to search formSkip to main contentSkip to account menu

AZD0865

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

ImidazolesPyridines
linaprazan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Predictors of either rapid healing or refractory reflux oesophagitis during treatment with potent acid suppression
Little is known regarding patient characteristics that influence the speed of reflux oesophagitis (RO) healing. 
2014
2014
Evaluation of the use of Classical Nucleation Theory for predicting intestinal crystalline precipitation of two weakly basic BSC class II drugs.
2013
2013
Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy
Objective Limited data exist on the impact of regurgitation on health-related quality of life (HRQOL) in gastro-oesophageal… 
Highly Cited
2012
Highly Cited
2012
Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease.
Highly Cited
2012
Highly Cited
2012
An In Vitro Methodology for Forecasting Luminal Concentrations and Precipitation of Highly Permeable Lipophilic Weak Bases in the Fasted Upper Small Intestine
PurposeTo develop an in vitro methodology for prediction of concentrations and potential precipitation of highly permeable… 
Highly Cited
2010
Highly Cited
2010
Predicting Intestinal Precipitation—A Case Example for a Basic BCS Class II Drug
ABSTRACTPurposeTo investigate the prediction accuracy of in vitro and in vitro/in silico methods for in vivo intestinal… 
Highly Cited
2008
Highly Cited
2008
A Randomized, Comparative Trial of a Potassium-Competitive Acid Blocker (AZD0865) and Esomeprazole for the Treatment of Patients With Nonerosive Reflux Disease
OBJECTIVES:AZD0865 is a gastric acid-suppressing agent that has a rapid onset of action and long duration of effect. This double… 
Highly Cited
2007
Highly Cited
2007
A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis.
Review
2006
Review
2006
Acid Suppression Therapy: Where Do We Go from Here?
The dramatic success of pharmacological acid suppression in healing peptic ulcers and managing patients with gastroesophageal… 
2006
2006
Characteristics of the K+-competitive H+,K+-ATPase inhibitor AZD0865 in isolated rat gastric glands.
The gastric H+,K+-ATPase of the parietal cell is responsible for acid secretion in the stomach and is the main target in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License